Clinical Trial: First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A First in Human Clinical Study on the Safety and Tolerability of Two Escalating Single Doses of CHF 5633 (Synthetic Surfactant) in Preterm Neonates With Respiratory Distress Syn

Brief Summary: The aim of this study is to investigate the safety and tolerability of intratracheal administration of two different single doses of CHF 5633 in preterm neonates with RDS in terms of adverse events, adverse drug reactions, hematology and biochemistry values, the incidence of major neonatal morbidities including bronchopulmonary dysplasia (BPD) and mortality.